Want to see IN:JUBLPHARMA full AI Analyst Report?
Jubilant Pharmova Limited (JUBLPHARMA) Revenue
Jubilant Pharmova Limited Revenue
Jubilant Pharmova Limited had a revenue of 22.29B in the quarter ending Jun 30, 2026, with -2.65%. This bring the company's revenue in the last twelve months to 86.08B, Increased 3.97%. In the fiscal year ending Mar 31, 2026, Jubilant Pharmova Limited had annual revenue of 82.80B with 14.45% growth.
- Revenue (ttm)
- 86.08B
- Revenue Growth
- 16.27%
- P/S Ratio
- 1.78
- Revenue/Employee
- INR 12,965,236
- Employees
- 6,386
- Market Cap
- INR 147.29B
Revenue Chart
Jubilant Pharmova Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 82.80B | 10.45B | 14.45% |
| Mar 31, 2025 | 72.34B | 5.32B | 7.93% |
| Mar 31, 2024 | 67.03B | 4.21B | 6.71% |
| Mar 31, 2023 | 62.82B | 1.52B | 2.47% |
| Mar 31, 2022 | 61.30B | 316.29M | 0.52% |
| Mar 31, 2021 | 60.99B | 1.23B | 2.05% |
| Mar 31, 2020 | 59.76B | -31.35B | -34.41% |
| Mar 31, 2019 | 91.11B | 15.93B | 21.19% |
| Mar 31, 2018 | 75.18B | 16.56B | 28.26% |
| Mar 31, 2017 | 58.61B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:JUBLPHARMA | 86.08B |
| IN:ALIVUS | 11.90B |
| IN:GRANULES | 56.18B |
| IN:NEULANDLAB | 23.72B |
| IN:STAR | 48.59B |
| IN:WOCKPHARMA | 35.64B |